Figure 1
In vivo IFN-ү production induced by exposure to liposome formulations, compared against DDA:TDB provides in vivo liposome efficacy. Data from in vivo papers referenced within the figure were taken for each liposome formulation. (a) Shows a summary table combining data, from all study 1 papers, of IFN-ү production shown as the percentage of DDA:TDB, and the corresponding in vivo strength category established as ‘+++’ > 80%, ‘++’ 50–79% and ‘+’ < 50%. (c) Shows a summary table combining data, from all study 2 papers, of IFN-ү production shown as the percentage of DDA:TDB, and the corresponding in vivo strength category established as ‘+++’ > 80%, ‘++’ 50–79% and ‘+’ < 50%. This data is represented in (b) and (d). Study 1 references: 1Hussain et al.33. 2Henriksen-Lacey et al.21. 3Henriksen-lacey et al.28. Study 2 references: 1Kaur et al.34; 2Kaur et al.35; 3Henriksen et al.21; 4Davidsen et al.18.
